Bulletin
Investor Alert

Fate Therapeutics Inc.

NAS: FATE

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Fate Therapeutics Inc.

After Hours

FATE
/zigman2/quotes/209623007/composite

$

5.00

Change

+0.13 +2.67%

Volume

Volume 33,555

Jun 9, 2023, 7:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209623007/composite

Previous close

$ 5.30

$ 4.87

Change

-0.43 -8.11%

Day low

Day high

$4.82

$5.37

Open
Open: 5.31

52 week low

52 week high

$4.02

$37.13

Open

Market cap

$479.13M

Average volume

2.31M

P/E ratio

N/A

Rev. per Employee

$248,396

EPS

-2.42

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/fate

MarketWatch News on FATE

  3. Fate Therapeutics downgraded to market perform at BMO Capital

    10:47 a.m. Jan. 6, 2023

    - Tomi Kilgore

  5. Fate Therapeutics downgraded to neutral from outperform at Wedbush

    8:59 a.m. Jan. 6, 2023

    - Tomi Kilgore

  6. Fate Therapeutics downgraded to hold from buy at Stifel Nicolaus

    8:48 a.m. Jan. 6, 2023

    - Tomi Kilgore

  7. Fate Therapeutics downgraded to perform from outperform at Oppenheimer

    8:58 a.m. Dec. 22, 2022

    - Tomi Kilgore

  15. Corbus Pharmaceuticals Holdings Inc. stock rises Monday, outperforms market

    5:46 p.m. Nov. 14, 2022

    - MarketWatch Automation

  16. 10 Stocks Driving the Biotech Resurgence

    8:49 a.m. Aug. 18, 2022

    - Barron's Online

  17. The Bull Market in Biotech Is Still Going Strong

    9:42 a.m. Aug. 4, 2022

    - Barron's Online

  18. 25 Stocks That Could Rise on a Short Squeeze

    9:30 p.m. July 22, 2022

    - Barron's Online

  20. Fate Therapeutics upgraded to outperform from market perform at BMO Capital

    7:21 a.m. July 12, 2022

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/fate

Other News on FATE

  2. 3 Graham's Lost Formula Picks to Consider for the New Year

    12:41 p.m. Jan. 5, 2023

    - GuruFocus.com

  3. Fate Therapeutics, Inc. (FATE) Q3 2022 Earnings Call Transcript

    11:56 p.m. Nov. 3, 2022

    - Seeking Alpha

  5. 10-Q: FATE THERAPEUTICS INC

    4:10 p.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Should You Invest in the SPDR S&P Biotech ETF (XBI)?

    6:20 a.m. Sept. 5, 2022

    - Zacks.com

/news/pressrelease/company/us/fate

Press Releases on FATE

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.